News Image

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress

Provided By GlobeNewswire

Last update: May 14, 2025

WATERTOWN, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple programs in its hematology portfolio at the upcoming European Hematology Association (EHA) 2025 Congress, which will be held in Milan, Italy on June 12-15, 2025.

Read more at globenewswire.com

DISC MEDICINE INC

NASDAQ:IRON (6/20/2025, 8:00:02 PM)

After market: 51.61 0 (0%)

51.61

+1.52 (+3.03%)



Find more stocks in the Stock Screener

Follow ChartMill for more